Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Management of prostate cancer in HIV-positive patients.

Wosnitzer MS, Lowe FC.

Nat Rev Urol. 2010 Jun;7(6):348-57. doi: 10.1038/nrurol.2010.61. Epub 2010 Apr 27. Review.

PMID:
20421876
2.
3.

Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study.

Pantanowitz L, Bohac G, Cooley TP, Aboulafia D, Dezube BJ.

BJU Int. 2008 Jun;101(12):1519-23. doi: 10.1111/j.1464-410X.2008.07474.x. Epub 2008 Apr 2.

4.

HIV and prostate cancer: a systematic review of the literature.

Silberstein J, Downs T, Lakin C, Kane CJ.

Prostate Cancer Prostatic Dis. 2009;12(1):6-12. doi: 10.1038/pcan.2008.44. Epub 2008 Aug 19. Review.

PMID:
18711409
5.
6.

Prostate carcinoma among men with human immunodeficiency virus infection.

Crum NF, Spencer CR, Amling CL.

Cancer. 2004 Jul 15;101(2):294-9.

7.

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Carter HB.

BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318. Review.

8.

Lung cancer in HIV positive patients: the GICAT experience.

Bearz A, Vaccher E, Martellotta F, Spina M, Talamini R, Lleshi A, Cacopardo B, Nunnari G, Berretta M, Tirelli U; Italian Cooperative Group on AIDS and Tumors.

Eur Rev Med Pharmacol Sci. 2014;18(4):500-8.

9.

Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus.

Levinson A, Nagler EA, Lowe FC.

Urology. 2005 Jan;65(1):91-4. Review.

PMID:
15667871
10.

Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.

D'Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, Jacobson LP.

J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):491-9. doi: 10.1097/QAI.0b013e31817aebfe.

11.

Anal dysplasia screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(4):1-43. Epub 2007 Jun 1.

12.

Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy.

Dorrucci M, Suligoi B, Serraino D, Tirelli U, Rezza G; Italian HIV-Seroconversion Study.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):377-80.

PMID:
11317082
13.

AIDS malignancies in the era of highly active antiretroviral therapy.

Gates AE, Kaplan LD.

Oncology (Williston Park). 2002 Apr;16(4):441-51, 456, 459. Review.

14.

Matched cohort analysis of outcomes of definitive radiotherapy for prostate cancer in human immunodeficiency virus-positive patients.

Kahn S, Jani A, Edelman S, Rossi P, Godette K, Landry J, Anderson C.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):16-21. doi: 10.1016/j.ijrobp.2011.05.047. Epub 2011 Nov 19.

PMID:
22104362
15.

Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men.

Marcus JL, Chao CR, Leyden WA, Xu L, Klein DB, Horberg MA, Towner WJ, Quesenberry CP Jr, Abrams DI, Van Den Eeden SK, Silverberg MJ.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):495-502. doi: 10.1097/QAI.0000000000000202.

PMID:
24820107
16.

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.

Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N.

J Int AIDS Soc. 2011 Mar 28;14:16. doi: 10.1186/1758-2652-14-16.

17.

Prostate cancer in HIV-positive individuals: what we know and what we don't.

Walters Z, Shamash J, Powles T.

J HIV Ther. 2007 Sep;12(3):66-7. No abstract available.

PMID:
17962795
18.

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Møller H, Bower M.

J Clin Oncol. 2009 Feb 20;27(6):884-90. doi: 10.1200/JCO.2008.19.6626. Epub 2008 Dec 29.

PMID:
19114688
19.

AIDS malignancies in the era of highly active antiretroviral therapy.

Gates AE, Kaplan LD.

Oncology (Williston Park). 2002 May;16(5):657-65; discussion 665, 668-70. Review.

20.

Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programme.

Gondos A, Krilaviciute A, Smailyte G, Ulys A, Brenner H.

Eur J Cancer. 2015 Aug;51(12):1630-7. doi: 10.1016/j.ejca.2015.04.009. Epub 2015 Jun 1.

PMID:
26044924

Supplemental Content

Support Center